199 related articles for article (PubMed ID: 23698748)
21. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
22. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
[TBL] [Abstract][Full Text] [Related]
23. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
24. Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice.
Lin SI; Huang MH; Chang YW; Chen IH; Roffler S; Chen BM; Sher YP; Liu SJ
Cancer Lett; 2016 Jul; 377(2):126-33. PubMed ID: 27130449
[TBL] [Abstract][Full Text] [Related]
25. In Silico-Guided Sequence Modification of Epitopes in Cancer Vaccine Development.
Hoo WPY; Siak PY; In LLA
Methods Mol Biol; 2020; 2131():213-228. PubMed ID: 32162256
[TBL] [Abstract][Full Text] [Related]
26. Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cells.
Gritzapis AD; Voutsas IF; Lekka E; Papamichail M; Baxevanis CN
Cancer Res; 2010 Apr; 70(7):2686-96. PubMed ID: 20233867
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer.
Ebben JD; Lubet RA; Gad E; Disis ML; You M
Mol Carcinog; 2016 Nov; 55(11):1517-1525. PubMed ID: 26346412
[TBL] [Abstract][Full Text] [Related]
28. LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model.
Rosenthal KS; Stone S; Koski G; Zimmerman DH
J Immunol Res; 2017; 2017():3613505. PubMed ID: 28459074
[TBL] [Abstract][Full Text] [Related]
29. Construction of a Recombinant Phage-vaccine Capable of Reducing the Growth Rate of an Established LL2 Tumor Model.
Asadi-Ghalehni M; Rasaee MJ; Namvar Asl N; Khosravani M; Rajabibazl M; Khalili S; Modjtahedi H; Sadroddiny E
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):240-249. PubMed ID: 29908541
[TBL] [Abstract][Full Text] [Related]
30. Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors.
Nava-Parada P; Forni G; Knutson KL; Pease LR; Celis E
Cancer Res; 2007 Feb; 67(3):1326-34. PubMed ID: 17283170
[TBL] [Abstract][Full Text] [Related]
31. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab.
Wang A; Cui M; Qu H; Di J; Wang Z; Xing J; Wu F; Wu W; Wang X; Shen L; Jiang B; Su X
Oncotarget; 2016 Nov; 7(46):75293-75306. PubMed ID: 27659529
[TBL] [Abstract][Full Text] [Related]
32. A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.
Boran AD; Seco J; Jayaraman V; Jayaraman G; Zhao S; Reddy S; Chen Y; Iyengar R
PLoS One; 2012; 7(11):e49702. PubMed ID: 23166750
[TBL] [Abstract][Full Text] [Related]
33. Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.
Kaumaya PT; Foy KC
Future Oncol; 2012 Aug; 8(8):961-87. PubMed ID: 22894670
[TBL] [Abstract][Full Text] [Related]
34. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.
Rice J; Elliott T; Buchan S; Stevenson FK
J Immunol; 2001 Aug; 167(3):1558-65. PubMed ID: 11466377
[TBL] [Abstract][Full Text] [Related]
35. B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine.
Kaumaya PT
Future Oncol; 2020 Aug; 16(23):1767-1791. PubMed ID: 32564612
[TBL] [Abstract][Full Text] [Related]
36. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
[TBL] [Abstract][Full Text] [Related]
37. The Immunogenicity and Anti-Tumor Efficacy of a Rationally Designed EGFR Vaccine.
Cheng C; Deng L; Li R
Cell Physiol Biochem; 2018; 46(1):46-56. PubMed ID: 29566364
[TBL] [Abstract][Full Text] [Related]
38. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
39. Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.
Naik H; Gauthier T; Singh S; Jois S
Bioorg Med Chem Lett; 2018 Dec; 28(22):3506-3513. PubMed ID: 30314880
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]